146 related articles for article (PubMed ID: 37721485)
1. Optimal left ventricular ejection fraction in risk stratification of patients with cardiac sarcoidosis.
Hutt E; Brizneda MV; Goldar G; Aguilera J; Wang TKM; Taimeh Z; Culver D; Callahan T; Tang WHW; Cremer PC; Jaber WA; Ribeiro Neto ML; Jellis CL
Europace; 2023 Aug; 25(9):. PubMed ID: 37721485
[TBL] [Abstract][Full Text] [Related]
2. Risk of Adverse Cardiovascular Events in Cardiac Sarcoidosis Independent of Left Ventricular Function.
Rosenthal DG; Cheng RK; Petek BJ; Masri SC; Mikacenic C; Raghu G; Patton KK
Am J Cardiol; 2020 Jul; 127():142-148. PubMed ID: 32402485
[TBL] [Abstract][Full Text] [Related]
3. Predictors of outcome in a contemporary cardiac sarcoidosis population: Role of brain natriuretic peptide, left ventricular function and myocardial inflammation.
Kouranos V; Khattar RS; Okafor J; Ahmed R; Azzu A; Baksi JA; Wechalekar K; Cowie MR; Wells AU; Lüscher TF; Sharma R
Eur J Heart Fail; 2023 Dec; 25(12):2287-2298. PubMed ID: 37877328
[TBL] [Abstract][Full Text] [Related]
4. "Function follows form": Role of cardiac magnetic resonance for ventricular arrhythmia risk stratification in patients with cardiac sarcoidosis.
Magnocavallo M; Vetta G; Polselli M; Cauti FM; Parlavecchio A; Caminiti R; Crea P; Pannone L; Sorgente A; Chimenti C; Chierchia GB; Rossi P; Natale A; de Asmundis C; Bianchi S; Della Rocca DG
J Cardiovasc Electrophysiol; 2023 Aug; 34(8):1781-1784. PubMed ID: 37493490
[TBL] [Abstract][Full Text] [Related]
5. Electrophysiology study for risk stratification in patients with cardiac sarcoidosis and abnormal cardiac imaging.
Okada DR; Smith J; Derakhshan A; Gowani Z; Zimmerman SL; Misra S; Berger RD; Calkins H; Tandri H; Chrispin J
Int J Cardiol Heart Vasc; 2019 Jun; 23():100342. PubMed ID: 31321283
[TBL] [Abstract][Full Text] [Related]
6. Value of CMR and PET in Predicting Ventricular Arrhythmias in Ischemic Cardiomyopathy Patients Eligible for ICD.
Rijnierse MT; van der Lingen ACJ; de Haan S; Becker MAJ; Harms HJ; Huisman MC; Lammertsma AA; van de Ven PM; van Rossum AC; Knaapen P; Allaart CP
JACC Cardiovasc Imaging; 2020 Aug; 13(8):1755-1766. PubMed ID: 32305468
[TBL] [Abstract][Full Text] [Related]
7. Utility of Cardiac Magnetic Resonance Imaging Versus Cardiac Positron Emission Tomography for Risk Stratification for Ventricular Arrhythmias in Patients With Cardiac Sarcoidosis.
Gowani Z; Habibi M; Okada DR; Smith J; Derakhshan A; Zimmerman SL; Misra S; Gilotra NA; Berger RD; Calkins H; Tandri H; Chrispin J
Am J Cardiol; 2020 Nov; 134():123-129. PubMed ID: 32950203
[TBL] [Abstract][Full Text] [Related]
8. Relationship of Mild to Moderate Impairment of Left Ventricular Ejection Fraction With Fatal Ventricular Arrhythmic Events in Cardiac Sarcoidosis.
Akama Y; Fujimoto Y; Matsue Y; Maeda D; Yoshioka K; Dotare T; Sunayama T; Nabeta T; Naruse Y; Kitai T; Taniguchi T; Sato S; Tanaka H; Okumura T; Baba Y; Minamino T
J Am Heart Assoc; 2024 Mar; 13(6):e032047. PubMed ID: 38456399
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac sarcoidosis.
Wicks EC; Menezes LJ; Barnes A; Mohiddin SA; Sekhri N; Porter JC; Booth HL; Garrett E; Patel RS; Pavlou M; Groves AM; Elliott PM
Eur Heart J Cardiovasc Imaging; 2018 Jul; 19(7):757-767. PubMed ID: 29319785
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of positron emission tomography in the evaluation of suspected cardiac sarcoidosis.
Patel VN; Pieper JA; Poitrasson-Rivière A; Kopin D; Cascino T; Aaronson K; Murthy VL; Koelling T
J Nucl Cardiol; 2022 Oct; 29(5):2460-2470. PubMed ID: 34505261
[TBL] [Abstract][Full Text] [Related]
11. Utility of electrophysiologic testing for sudden death risk stratification in cardiac sarcoidosis patients with mildly impaired left ventricular function.
Tandon P; Mosleh T; Mustafa A; Miodownik H; Miller M; Morgenthau AS
Respir Med; 2022 Jan; 191():106712. PubMed ID: 34906899
[TBL] [Abstract][Full Text] [Related]
12. Cardiac sarcoidosis outcome differences: A comparison of patients with de novo cardiac versus known extracardiac sarcoidosis at presentation.
Rosen NS; Pavlovic N; Duvall C; Wand AL; Griffin JM; Okada DR; Chrispin J; Tandri H; Mathai SC; Stern B; Pardo CA; Kasper EK; Sharp M; Chen ES; Gilotra NA
Respir Med; 2022 Jul; 198():106864. PubMed ID: 35550245
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiologic testing for diagnostic evaluation and risk stratification in patients with suspected cardiac sarcoidosis with preserved left and right ventricular systolic function.
Zipse MM; Tzou WS; Schuller JL; Aleong RG; Varosy PD; Tompkins C; Borne RT; Tumolo AZ; Sandhu A; Kim D; Freeman AM; Weinberger HD; Maier LA; Sung RK; Nguyen DT; Sauer WH
J Cardiovasc Electrophysiol; 2019 Oct; 30(10):1939-1948. PubMed ID: 31257683
[TBL] [Abstract][Full Text] [Related]
14. Regional abnormalities on cardiac magnetic resonance imaging and arrhythmic events in patients with cardiac sarcoidosis.
Okada DR; Xie E; Assis F; Smith J; Derakhshan A; Gowani Z; Ambale-Venkatesh B; Gilotra NA; Zimmerman SL; Berger RD; Calkins H; Lima JAC; Tandri H; Chrispin J
J Cardiovasc Electrophysiol; 2019 Oct; 30(10):1967-1976. PubMed ID: 31328324
[TBL] [Abstract][Full Text] [Related]
15. Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation.
Klem I; Weinsaft JW; Bahnson TD; Hegland D; Kim HW; Hayes B; Parker MA; Judd RM; Kim RJ
J Am Coll Cardiol; 2012 Jul; 60(5):408-20. PubMed ID: 22835669
[TBL] [Abstract][Full Text] [Related]
16. [The value of cardiac MRI in the risk stratification in patients with hypertrophic cardiomyopathy].
Wang JX; Yang SJ; Ma X; Yu SQ; Dong ZX; Xiang XR; Wei ZX; Cui C; Yang K; Chen XY; Lu MJ; Zhao SH
Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Jun; 51(6):619-625. PubMed ID: 37312480
[No Abstract] [Full Text] [Related]
17. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.
Blankstein R; Osborne M; Naya M; Waller A; Kim CK; Murthy VL; Kazemian P; Kwong RY; Tokuda M; Skali H; Padera R; Hainer J; Stevenson WG; Dorbala S; Di Carli MF
J Am Coll Cardiol; 2014 Feb; 63(4):329-36. PubMed ID: 24140661
[TBL] [Abstract][Full Text] [Related]
18. Associations between scar characteristics by cardiac magnetic resonance and changes in left ventricular ejection fraction in primary prevention defibrillator recipients.
Zhang Y; Guallar E; Weiss RG; Stillabower M; Gerstenblith G; Tomaselli GF; Wu KC
Heart Rhythm; 2016 Aug; 13(8):1661-6. PubMed ID: 27108939
[TBL] [Abstract][Full Text] [Related]
19. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis.
Greulich S; Deluigi CC; Gloekler S; Wahl A; Zürn C; Kramer U; Nothnagel D; Bültel H; Schumm J; Grün S; Ong P; Wagner A; Schneider S; Nassenstein K; Gawaz M; Sechtem U; Bruder O; Mahrholdt H
JACC Cardiovasc Imaging; 2013 Apr; 6(4):501-11. PubMed ID: 23498675
[TBL] [Abstract][Full Text] [Related]
20. Right Ventricular Abnormalities on Cardiovascular Magnetic Resonance Imaging in Patients With Sarcoidosis.
Velangi PS; Chen KA; Kazmirczak F; Okasha O; von Wald L; Roukoz H; Farzaneh-Far A; Markowitz J; Nijjar PS; Bhargava M; Perlman D; Akçakaya M; Shenoy C
JACC Cardiovasc Imaging; 2020 Jun; 13(6):1395-1405. PubMed ID: 31954639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
